Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.825 USD | -1.51% | +1.26% | -35.64% |
Apr. 17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
Apr. 11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Sales 2024 * | 115M 76.23M | Sales 2025 * | 164M 108M | Capitalization | 352M 232M |
---|---|---|---|---|---|
Net income 2024 * | -56M -37.02M | Net income 2025 * | -17M -11.24M | EV / Sales 2024 * | 2.88 x |
Net cash position 2024 * | 19.8M 13.09M | Net cash position 2025 * | 1.85M 1.23M | EV / Sales 2025 * | 2.14 x |
P/E ratio 2024 * |
-6.18
x | P/E ratio 2025 * |
-31.1
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on AVITA Medical, Inc.
1 day | -1.45% | ||
1 week | +1.26% | ||
Current month | +5.12% | ||
1 month | -41.02% | ||
3 months | -50.94% | ||
6 months | -10.63% | ||
Current year | -35.64% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 4 M€ | -5.15% | - | |
0.00% | 0 M€ | +3.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 8.84 | -1.34% | 198 121 |
24-05-08 | 8.96 | -4.38% | 371,776 |
24-05-07 | 9.37 | +5.28% | 171,445 |
24-05-06 | 8.9 | +1.71% | 131,256 |
24-05-03 | 8.75 | +0.34% | 142,531 |
Delayed Quote Nasdaq, May 09, 2024 at 01:54 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.64% | 231M | |
+24.67% | 46.71B | |
+48.83% | 41.8B | |
-1.05% | 41.52B | |
-5.86% | 29.55B | |
+10.86% | 25.78B | |
-20.48% | 19.26B | |
+2.40% | 12.14B | |
-2.54% | 12.08B | |
+28.38% | 11.98B |
- Stock Market
- Equities
- RCEL Stock